↓ Skip to main content

CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer

Overview of attention for article published in Breast Cancer Research, December 2007
Altmetric Badge

Mentioned by

patent
3 patents

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
30 Mendeley
citeulike
1 CiteULike